Select Clinical Trial
Protocol Number: Matisse C3671008, NCT04424316
Protocol Title: Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Pre-Fusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy
Eligibility: Pregnant women age 18 and older, 24-36 weeks gestation with estimated delivery dates before February 12, 2021.
Contact Information: (910) 715-2200